Recent developments of interest in cardiovascular medicine
The first U.S. case of adult heart transplant from donation after circulatory death was done using a warm perfusion machine in a pivotal trial, the New York Post reported; MedPage Today has background here.
A "human heart-in-a-jar" organoid technology is being developed as a model for heart failure with preserved ejection fraction. (Xconomy)
Among the medicines that make U.S. prescriptions the most expensive in the world, the ACE inhibitor lisinopril sold as Zestril had the biggest price differential -- almost 28 times the global median. (Becker's Hospital Review)
Lung cancer screening CT scans can pull double duty with an artificial intelligence analysis for coronary artery calcium scores, researchers reported at the Radiological Society of North America meeting in Chicago. (AI in Healthcare)
Frequent tooth-brushers are also less likely to have atrial fibrillation or heart failure. (European Journal of Preventive Cardiology)
Continued access registries for the PROTECT AF and PREVAIL trials showed 69% to 78% fewer total strokes than expected based on risk scores despite 95% being off anticoagulation at 1 year after getting the Watchman device for prevention in non-valvular atrial fibrillation. (Journal of the American College of Cardiology)
Want to visualize the number of deaths from cardiovascular causes compared to, say, sharks or war? Check this tweet.
An employee wellness program helped about one-third of people who participated for at least a year to drop into a lower 10-year cardiovascular risk category. (Journal of Population Health Management)
Public reporting of hypertension control rates could be "motivating," according to an opinion piece in High Blood Pressure & Cardiovascular Prevention.
Read the original article on Medpage Today: Heart Transplant Milestone; HFpEF in a Jar; Multipurpose CT Screen